Shoulder–arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer
- 1 November 2002
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 28 (7), 705-710
- https://doi.org/10.1053/ejso.2002.1327
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?Cancer, 2001
- Das Multi Center Database Project (MCDBP)European Surgery, 2001
- Sentinel node biopsy should be introduced into routine practice before results of randomized trials are availableThe Breast, 2001
- Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancerThe Lancet, 2001
- A Survival Benefit From Axillary Dissection: Was Halsted Correct?Annals of Surgical Oncology, 1999
- Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage i. results from a randomised trialEuropean Journal Of Cancer, 1997
- Improved Axillary Staging of Breast Cancer with Sentinel LymphadenectomyAnnals of Surgery, 1995
- Lymphatic Mapping and Sentinel Lymphadenectomy for Breast CancerAnnals of Surgery, 1994
- Arm Morbidity following Treatment of Breast Cancer with Total Axillary Dissection A Multivariated ApproachOncology, 1993
- Risk of lymphoedema following the treatment of breast cancerBritish Journal of Surgery, 1986